Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials
Circulation
NOVEMBER 11, 2023
Oral anticoagulation also reduced a composite of cardiovascular death, all-cause stroke, peripheral arterial embolism, myocardial infarction or pulmonary embolism (RR 0.85, 95% CI 0.73-1.00, We used random-effects models for meta-analysis and rated the quality of evidence using the GRADE framework. I2=0%; moderate-quality evidence).
Let's personalize your content